Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inflammatory demyelinating neuropathies: classification, evolution and prognosis].

Alain Créange1, Delphine Boërio, Jean-Pascal Lefaucheur

  • 1Service de Neurologie, Hôpital Henri Mondor, Créteil Cedex, France. creange@univ-paris12.fr

Journal De La Societe De Biologie
|July 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DN4 Is Not a Screening Tool for Small Fiber Neuropathy: An Expected Result.

European journal of neurology·2026
Same author

Initial treatment choice for multiple sclerosis and prognosis at year 3 are associated with few poor prognosis factors.

Multiple sclerosis and related disorders·2026
Same author

Case Report: a novel <i>PNPLA2</i> homozygous frameshift variant causing severe neutral lipid storage disease with myopathy (NLSDM) in a Moroccan patient.

Frontiers in genetics·2026
Same author

Evaluation of the usability of the spinal cord stimulator recharging procedure in the treatment of neuropathic pain. A quantitative and qualitative study.

Frontiers in pain research (Lausanne, Switzerland)·2026
Same author

The intrinsic reason why it is relevant to introduce the concept of "small fiber neuralgia" into the taxonomy of pain disorders.

Frontiers in pain research (Lausanne, Switzerland)·2026
Same author

Home use of low-intensity transcranial electrical stimulation in clinical practice: an IFCN handbook chapter.

Clinical neurophysiology practice·2026
Same journal

[Food safety of GMOs].

Journal de la Societe de biologie·2010
Same journal

[Placing on the market, breeders rights and growing genetically modified (GM) varieties].

Journal de la Societe de biologie·2010
Same journal

[Cultivation and environmental impacts of GMO crops].

Journal de la Societe de biologie·2010
Same journal

[Applications of genetically modified animals].

Journal de la Societe de biologie·2010
Same journal

[Why GMOs].

Journal de la Societe de biologie·2010
Same journal

[Mutations in renin-angiotensin system genes and kidney developmental anomalies].

Journal de la Societe de biologie·2010
See all related articles

Inflammatory demyelinating neuropathies vary by lesion location and clinical presentation. Understanding their diverse mechanisms is key to preventing permanent nerve damage.

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Background:

  • Inflammatory demyelinating neuropathies present with diverse clinical features based on lesion topography.
  • These neuropathies can exhibit remittent or progressive courses, with a risk of permanent axonal damage and neurological deficits.
  • Pathogenic mechanisms differ based on antigenic targets and immunological profiles (cellular vs. humoral).

Purpose of the Study:

  • To classify inflammatory demyelinating neuropathies based on lesion topography.
  • To elucidate the varying clinical characteristics and courses of different neuropathy types.
  • To differentiate neuropathies by underlying mechanisms and guide therapeutic strategies.

Main Methods:

  • Classification of neuropathies by lesion site: proximal (polyradiculoneuritis), nerve trunks (multifocal motor/sensory-motor), or distal (anti-MAG IgM).

Related Experiment Videos

  • Analysis of clinical presentations, disease courses (remittent/progressive), and risk factors for axonal lesions.
  • Differentiation of immunological mechanisms based on antigenic targets and immune response types.

    • Main Results:

    • Polyradiculoneuritis shows diffuse, proximal lesions; multifocal neuropathies have localized conduction blocks; anti-MAG IgM neuropathies are distal and symmetric.
    • Clinical variability is linked to specific neuropathy types, with potential for irreversible axonal damage.
    • Distinct antigenic targets and immune responses necessitate tailored therapeutic approaches.

    Conclusions:

    • Topographical classification aids in understanding inflammatory demyelinating neuropathies.
    • Recognizing diverse mechanisms is crucial for effective treatment and preventing neurological deficits.
    • The inflammatory process involves energy failure, impacting ion pumps and leading to axonal degeneration.